Sayitoglu, M. Et Al. 2009. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.. The Journal of international medical research , vol.37, no.4 , 1018-28.

Sayitoglu, M., Haznedaroğlu, İ. C., Hatirnaz, O., Erbilgin, Y., Aksu, S., Koca, E., ... Adiguzel, C.(2009). Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.. The Journal of international medical research , vol.37, no.4, 1018-28.

Sayitoglu, Müge Et Al. "Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.," The Journal of international medical research , vol.37, no.4, 1018-28, 2009

Sayitoglu, Müge Et Al. "Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.." The Journal of international medical research , vol.37, no.4, pp.1018-28, 2009

Sayitoglu, M. Et Al. (2009) . "Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.." The Journal of international medical research , vol.37, no.4, pp.1018-28.

@article{article, author={Müge SAYİTOĞLU Et Al. }, title={Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.}, journal={The Journal of international medical research}, year=2009, pages={1018-28} }